Showing Results for: “diabetes exercise”

“The American Diabetes Association ® (ADA) is the leading voice advocating for insulin affordability and is working to ensure that all people with diabetes have access to the care they need. The ADA has led the charge to enact cost-sharing limits on insulin in 22 states and D.C., and now the first-ever federal copay cap in Medicare. We are pleased that more manufacturers are continuing to take steps to make insulin more affordable, and we hope others follow suit. ADA will keep working to make sure drug rebates are not inflating costs for patients at the pharmacy counter, and we will continue

American Heart Association ® and American Diabetes Association ® reveal results of Know Diabetes by Heart ™ survey and share practical tips for staying on track with health goals through the holiday season Nearly half (49%) of people living with type 2 diabetes said managing their condition during a typical fall and winter holiday season is more difficult than other times of the year, according to a new survey for the American Heart Association and American Diabetes Association. The online survey of more than 1,000 U.S. adults 45 and older completed by real-time market research platform

Senate Reconciliation Bill Would Reduce the Price of Insulin Today, Senate Democrats, including Senate Diabetes Caucus Co-Chair Sen. Jeanne Shaheen (D-NH), announced potential updates to the Inflation Reduction Act, which was released earlier this week. The Senate bill could now include a $35 monthly cap on out-of-pocket costs for insulin, and it could also allow Medicare to directly negotiate the price of insulin products with drug manufacturers. The American Diabetes Association® (ADA) has been the leading advocate for insulin copay caps across the country, resulting in the enactment of

BODi will help provide healthy lifestyle solutions to 136 million Americans with diabetes or prediabetes The Beachbody Company, Inc. (NYSE: BODI) (“BODi” or the “Company”), a leading fitness and nutrition company, announced today that it has become an Official Wellness Supporter of the American Diabetes Association® (ADA). BODi and the ADA will work together to improve the lives of the 136 million Americans who live with diabetes or prediabetes. Regular physical activity improves health outcomes and reduces the risk of developing type 2 diabetes, with the ADA advising at least 150 minutes per

The American Diabetes Association® (ADA) announced on July 8 that Chief Scientific and Medical Officer (CSMO) Dr. Robert Gabbay has chosen to step down from his role to reduce his professional commitments and transition into semi-retirement. Dr. Gabbay's last day will be September 6. “We owe a debt of gratitude to Dr. Bob for his unwavering dedication and the profound impact he has made during his tenure,” said Charles “Chuck” Henderson, chief executive officer of the ADA. “As we move forward, guided by his legacy and the enduring deep expertise of the ADA’s Science and Health Care team, I am

Leading Diabetes Scientific Sessions Meeting Brings Together Researchers From Around the World With Hybrid Format Today, the American Diabetes Association ® (ADA) kicks off the 82nd Scientific Sessions in New Orleans, LA. The ADA’s Scientific Sessions is the world’s premier meeting in diabetes with a broader reach than ever with hybrid options for attendees. The meeting will take part live and virtually from around the globe today, June 3, through June 7 at the Ernest N. Morial Convention Center, presenting the latest cutting-edge advances in diabetes research, prevention, and care. This year

The American Heart Association and the American Diabetes Association expand landmark Know Diabetes by Heart™ collaboration with Spanish campaign American Heart Association and American Diabetes Association aims to increase awareness and action among Spanish language-dominant people with type 2 diabetes to underscore the link between type 2 diabetes and heart disease and stroke. The announcement comes during Hispanic Heritage Month (September 15 – October 15). The Spanish-language campaign, found at DiabetesdeCorazon.org , is an extension of the American Heart Association and the American

Children with early-onset type 1 diabetes (T1D) and poor glycemic control have slower growth of areas in the brain associated with mild cognitive deficits compared to children without diabetes, according to the study, “ADA Presidents' Select Abstract: Type 1 Diabetes and the Developing Brain—A Longitudinal Study of Brain Growth by the Diabetes Research in Children Network (DirecNet),” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. The study found that children with early-onset T1D have mild but

Pancreatic beta cells that do not produce sufficient insulin in people with type 2 diabetes (T2D) are not permanently damaged during the early stages of the disease and can be restored to normal function through the removal of excess fat in the cells, according to a study entitled “Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT)” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions®. More than one-third (36%) of the participants who took part in an

The American Diabetes Association ® applauds last week’s ruling by Florida’s Second Circuit Court striking down Florida Governor DeSantis’ Executive Order banning local school boards from implementing mask mandates. The decision held that school districts can adopt health care policies over parental disagreements. The Judge referenced two Florida Supreme Court decisions supporting limiting individual rights when impacting the rights of others. The Judge further stated that the governor’s and state agencies’ actions in banning mask mandates don’t pass “Constitutional muster.” Attending school